]>
IRCT20211219053452N1 IRCT 2022-06-25 Arak University of Medical Sciences The Effect of Atomoxetine on Cognitive Symptoms in Schizophrenia Patients The Effect of Atomoxetine on Cognitive Symptoms in Schizophrenia Patients 2022-04-21 anticipated 40 Complete https://irct.ir/trial/62910 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: A simple random method based on the patients' record number (odd and even) will be divided into two completely equal groups of atomoxetine and placebo groups (neutral and inert substances such as starch) that have no pharmacological effect on the patient, Blinding description: The researcher and the patient are both unaware of which group they belong to, and the patients, in pairs and individually, are completely equal to the two groups of atomoxetine and the placebo group (a neutral and inert substance like starch in appearance similar to atomoxetine) that has no pharmacological effect on They do not affect the patient and will be divided on the assumption that the drug has a pharmacological or physiological effect on the patient's condition. 3 Schizophrenia. Intervention 1: Intervention group: Patients are given 40 mg of atomoxetine daily for 8 weeks. Intervention 2: Control group: Similar tablets in terms of size and color of atomoxetine are prepared from starch and will be given to patients daily for 8 weeks. Yes - There is a plan to make this available What will be shared: All data is potentially shareable after unidentifiable individuals When: Start the access period immediately after printing the results To whom: Study data will be available to researchers working at academic and scientific institutes Conditions: Any analysis on unidentifiable individual data is allowed. Where to obtain: Send your request via email How to obtain: Documents or data files will be sent to the applicant after receiving the request Comments:
public Fatemeh Yousefi
Hepco St. - Imam Hossein St. - Golzar 11
Arak Iran (Islamic Republic of) 3818133150 +98 86 3367 7022 Fatemehyy75@gmail.com Arak University of Medical Sciences scientific Fatemeh Yousefi
Hepco St. - Imam Hossein St. - Golzar 11
Arak Iran (Islamic Republic of) 3818133150 +98 86 3367 7022 Fatemehyy75@gmail.com Arak University of Medical Sciences Iran (Islamic Republic of) Schizophrenia Get a score of 61 or higher on the panss questionnaire no limit no limit Both Simultaneous presence of other neurological disorders Any allergy to atomoxetine Patients who have received ECT in the last 6 weeks F20 Schizophrenia Treatment - Drugs Placebo Intervention group: Patients are given 40 mg of atomoxetine daily for 8 weeks Control group: Similar tablets in terms of size and color of atomoxetine are prepared from starch and will be given to patients daily for 8 weeks. Wechsler Short-Term Memory Test. Timepoint: Before the intervention and after 8 weeks of treatment. Method of measurement: Wechsler test. Short-term memory expansive score, direct visual memory, reverse visual memory, direct auditory memory, auditory reverse memory. Timepoint: Before the intervention and after 8 weeks of treatment. Method of measurement: How to measure short-term memory, direct visual memory, reverse visual memory, direct auditory memory, auditory reverse memory using Wechsler test. Arak University of Medical Sciences Approved 2022-04-13 Ethics Committee of Arak University of Medical Sciences Alam al-Huda St., Arak University of Medical Sciences Arak Markazi Iran (Islamic Republic of)